WO2013079536A1 - A meal intended for human consumption - Google Patents

A meal intended for human consumption Download PDF

Info

Publication number
WO2013079536A1
WO2013079536A1 PCT/EP2012/073846 EP2012073846W WO2013079536A1 WO 2013079536 A1 WO2013079536 A1 WO 2013079536A1 EP 2012073846 W EP2012073846 W EP 2012073846W WO 2013079536 A1 WO2013079536 A1 WO 2013079536A1
Authority
WO
WIPO (PCT)
Prior art keywords
meal
flavonoid
glucoside
meals
pal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/073846
Other languages
English (en)
French (fr)
Inventor
Mark John Berry
Heather Frances Jennifer Bligh
Mark Ian FOWLER
Karl John Hunter
Katrina MACAULAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hindustan Unilever Ltd
Unilever NV
Conopco Inc
Original Assignee
Hindustan Unilever Ltd
Unilever NV
Conopco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US14/359,487 priority Critical patent/US9386792B2/en
Priority to CA2852032A priority patent/CA2852032A1/en
Priority to EA201491050A priority patent/EA027364B1/ru
Priority to BR112014010107A priority patent/BR112014010107A2/pt
Priority to AU2012343964A priority patent/AU2012343964B2/en
Priority to CN201280058728.9A priority patent/CN104039170A/zh
Application filed by Hindustan Unilever Ltd, Unilever NV, Conopco Inc filed Critical Hindustan Unilever Ltd
Priority to IN932MUN2014 priority patent/IN2014MN00932A/en
Priority to EP12791209.5A priority patent/EP2785201A1/en
Publication of WO2013079536A1 publication Critical patent/WO2013079536A1/en
Priority to ZA2014/02770A priority patent/ZA201402770B/en
Anticipated expiration legal-status Critical
Priority to US15/179,203 priority patent/US9750272B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • This invention relates to a plurality of compositions for dietary health management and its use in the prevention or treatment of cardiovascular disease, type 2 diabetes and obesity; and in weight management and weight loss.
  • a method for the prevention or treatment of cardiovascular disease, type 2 diabetes and obesity; and for weight management and weight loss comprising the step of administering to a person in need therefor the meal of the first aspect of the invention.
  • dinner extracts expressed as a percentage relative to the activation of the EC80 concentration of reference agonist (40 g/ml aqueous methanol extract, 8 g/ml petroleum ether extract, 8 g/ml dichloromethane extract, 4 g/ml ethyl acetate extract, 40 g/ml 1 -butanol extract and 40 g/ml water extract);
  • reference agonist 40 g/ml aqueous methanol extract, 8 g/ml petroleum ether extract, 8 g/ml dichloromethane extract, 4 g/ml ethyl acetate extract, 40 g/ml 1 -butanol extract and 40 g/ml water extract
  • a petroleum ether (40-60 °C) extract of an aqueous methanol extract of the meal of the second aspect of the invention has a gallic acid equivalent of 5-40, preferably 15-30, more preferably 20-30 mg,
  • a dichloromethane extract of the aqueous methanol extract after petroleum ether (40-60 °C) extraction of the aqueous methanol extract has a gallic acid equivalent of 5-25, preferably 10-20, more preferably 13-18 mg,
  • Another aspect of the invention is the use of the claimed meal for the manufacture of a medicament for the prevention or treatment of cardiovascular disease, type 2 diabetes and obesity; and for weight management and weight loss.
  • apigenin, cyanidin-3-glucoside, delphinidin-3-glucoside, hesperetin, kaempferol, luteolin, malvidin-3-glucoside, myricetin, naringenin, pelagonidin-3-glucoside and quercetin was carried out by removing lipids from freeze-dried, ground foodstuffs by the method of Meyer, M. D. et al. , (J. Agric. Food Chem. , 56, 7439-7445 (2008)) and assaying the extracted flavanoids by HPLC as detailed in Downes, K. et al. , (Postharvest Biol. Technol.
  • Sugars were extracted with water, clarified and chromatographically separated on an amine column with an acetonitrile/water mobile phase. The sugars were detected using an evaporative light scattering detector and quantified with reference to calibration standards. Values were expressed as g.meal "1 .
  • Total dietary fibre was determined by precipitating soluble fibre before the removal of insoluble fibre, with the resultant precipitate washed, dried and weighed. Total dietary fibre was then determined gravimetrically and corrected for protein and ash. Values are expressed in units of g.meal "1 .
  • Blood samples were centrifuged at 4 degrees Centigrade and two samples of more than 500 ⁇ of EDTA plasma and two samples of more than 500 ⁇ heparin plasma were frozen and stored at -70 degrees Centigrade until analysis.
  • Venous plasma glucose analysis was conducted on a Horiba ABX Clinical Chemistry analyser using the commercially available Glucose PAP CP kit (ref A1 1 A01668) from ABX Pentra.
  • Table 6 Peak venous blood glucose values (mmol/L) between 0 (baseline before the meals) and 180 minutes after commencing meal consumption. P was calculated at 95 % confidence limits.
  • the PAL 2 glucose curve shows a much gentler decline between 30 and 60 minutes than for PAL 1 and Reference, and furthermore, unlike the other two curves, never goes significantly below baseline to show a post prandial "dip". This is likely to be related to the lower insulin peak shown in Figure 1 .
  • both PAL 1 and PAL 2 show increases in PYY, GLP-1 and decreases in GIP when compared with the Reference meal. All three of these results can be considered as favourable health outcomes. Whilst not wishing to be bound by any particular theory, the inventors believe that a possible explanation is that flavonoids or other phenolics in PAL 1 and PAL 2 activate receptors in the gut and these are responsible for the changes in hormones in the blood.
  • Residual solvent was removed from the remaining unextracted portion by rotary evaporation and the aqueous solution was freeze-dried.
  • the lyophilised sample was labelled as 'water extract' and stored at -20 °C under nitrogen in the dark. Extractions yielded the quantities of material set forth in Table 7.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/EP2012/073846 2011-11-29 2012-11-28 A meal intended for human consumption Ceased WO2013079536A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IN932MUN2014 IN2014MN00932A (https=) 2011-11-29 2012-11-28
CA2852032A CA2852032A1 (en) 2011-11-29 2012-11-28 A meal intended for human consumption
EA201491050A EA027364B1 (ru) 2011-11-29 2012-11-28 Набор продуктов для полного завтрака, обеда и ужина
BR112014010107A BR112014010107A2 (pt) 2011-11-29 2012-11-28 refeição destinada ao consumo humano, uso da refeição e método para a prevenção ou tratamento de doença cardiovascular, diabetes o tipo 2 e obesidade; e para o controle de peso e perda de peso
AU2012343964A AU2012343964B2 (en) 2011-11-29 2012-11-28 A meal intended for human consumption
US14/359,487 US9386792B2 (en) 2011-11-29 2012-11-28 Meal intended for human consumption
EP12791209.5A EP2785201A1 (en) 2011-11-29 2012-11-28 A meal intended for human consumption
CN201280058728.9A CN104039170A (zh) 2011-11-29 2012-11-28 旨在用于人食用的膳食
ZA2014/02770A ZA201402770B (en) 2011-11-29 2014-04-15 A meal intended for human consumption
US15/179,203 US9750272B2 (en) 2011-11-29 2016-06-10 Meal intended for human consumption

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11191182 2011-11-29
EP11191182.2 2011-11-29

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/359,487 A-371-Of-International US9386792B2 (en) 2011-11-29 2012-11-28 Meal intended for human consumption
US15/179,203 Continuation US9750272B2 (en) 2011-11-29 2016-06-10 Meal intended for human consumption

Publications (1)

Publication Number Publication Date
WO2013079536A1 true WO2013079536A1 (en) 2013-06-06

Family

ID=47226200

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/073846 Ceased WO2013079536A1 (en) 2011-11-29 2012-11-28 A meal intended for human consumption

Country Status (10)

Country Link
US (2) US9386792B2 (https=)
EP (1) EP2785201A1 (https=)
CN (1) CN104039170A (https=)
AU (1) AU2012343964B2 (https=)
BR (1) BR112014010107A2 (https=)
CA (1) CA2852032A1 (https=)
EA (1) EA027364B1 (https=)
IN (1) IN2014MN00932A (https=)
WO (1) WO2013079536A1 (https=)
ZA (1) ZA201402770B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015182955A (ja) * 2014-03-20 2015-10-22 学校法人中部大学 Ｇｌｐ−１分泌促進剤
WO2021252467A1 (en) * 2020-06-09 2021-12-16 H.J. Heinz Company Brands Llc Modular meal system
USD1057556S1 (en) 2021-10-29 2025-01-14 H. J. Heinz Company Brands Llc Tray

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111096972B (zh) * 2020-02-25 2023-07-14 成都医学院 一种预防和/或治疗阿尔茨海默症的药物组合物
CN115645431B (zh) * 2022-12-12 2023-03-21 汤臣倍健股份有限公司 一种组合物及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011147862A1 (en) * 2010-05-28 2011-12-01 Unilever Plc Compositions for dietary health management

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039989A (en) 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
WO1996039053A2 (en) 1995-06-06 1996-12-12 Campbell Soup Company Mineral supplements for dietetic food
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US20020054924A1 (en) * 2000-04-13 2002-05-09 Leahy Margaret M. Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
WO2002011562A2 (en) 2000-08-08 2002-02-14 Advanced Functional Foods International, Inc. Nutritional supplement for the management of weight
US6808727B2 (en) 2001-07-20 2004-10-26 Emanuel S. Kemeny Meal-equivalent food bar
US7030092B1 (en) * 2001-08-24 2006-04-18 Small Giant L.L.C. Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins.
US6585998B2 (en) * 2001-11-13 2003-07-01 Rudolph Cartwright Nutraceutical composition
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US7767245B2 (en) 2003-09-12 2010-08-03 Ray And Terry's Health Products, Inc. Meal replacement beverage
CA2577984C (en) 2004-08-25 2012-01-24 Regents Of The University Of Minnesota Compositions and methods to lower glycohemoglobin levels
US20060188590A1 (en) * 2005-01-05 2006-08-24 Mitsunori Ono Compositions for treating diabetes or obesity
US7977319B1 (en) * 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
US20080305096A1 (en) 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
US20100093678A1 (en) * 2008-10-10 2010-04-15 The University Of Georgia Research Foundation, Inc Compositions and methods of the treatment of obesity and osteoporosis
WO2010105253A2 (en) * 2009-03-13 2010-09-16 The Salk Institute For Biological Studies Methods and compositions for treating complications of diabetes and vascular diseases using flavones
EP2316271A1 (fr) 2009-10-26 2011-05-04 ET & DS Company Ltd Substitut de repas sous forme d'un aliment à cuire de type pain et d'un aliment d'accompagnement de type pâte à tartiner.
WO2011060307A2 (en) 2009-11-13 2011-05-19 Jingxuan Kang Food products having multiple health benefits
EP2509434A4 (en) 2009-12-07 2015-06-24 Leonardo Carella CALORIE ARMS, PROPERTY-FRIENDLY MOLDED FORMING AND MANUFACTURING METHOD
MX2013003985A (es) * 2010-10-14 2014-05-01 Asha Nutrition Sciences Inc Formulaciones nutritivas optimizadas, metodos para la seleccion de dietas adaptadas a partir de las mismas, y metodos para utilizar las mismas.
CN102077949B (zh) 2011-01-27 2013-01-16 北京康比特体育科技股份有限公司 一种减肥代餐营养棒及其制备方法
CN102224933B (zh) 2011-05-13 2013-07-17 烟台新时代健康产业有限公司 辅助调节血脂的组合物、保健食品及其应用
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
JP2015505320A (ja) * 2012-01-16 2015-02-19 グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー２、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｎｏ．２ Ｌｉｍｉｔｅｄ 糖尿病及び／又は肥満の治療のための組成物及び方法
US9132117B2 (en) * 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011147862A1 (en) * 2010-05-28 2011-12-01 Unilever Plc Compositions for dietary health management

Non-Patent Citations (34)

* Cited by examiner, † Cited by third party
Title
"Diet, nutrition and the prevention of chronic diseases", WHO TECHNICAL REPORT SERIES, no. 916, 2003
BATTERHAM ET AL., NATURE, vol. 418, 2002, pages 650 - 654
CORDAIN, J. AM. NUTRACEUTICAL ASS., vol. 5, no. 3, pages 15 - 24
CORDAIN: "J. Am. Nutraceutical Ass.", J. AM. NUTRACEUTICAL ASS., vol. 5, no. 3, 2002, pages 15 - 24
DILLARD C J ET AL: "Review Phytochemicals: nutraceuticals and human health", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, WILEY & SONS, CHICHESTER, GB, vol. 80, no. 12, 15 September 2000 (2000-09-15), pages 1744 - 1756, XP002616614, ISSN: 0022-5142, [retrieved on 20000728], DOI: _ *
DOWNES, K. ET AL., POSTHARVEST BIOL. TECHNOL., vol. 54, 2009, pages 80 - 86
DRUCKER, J OF CLIN INV, vol. 117, 2007, pages 24 - 32
FLINT A; RABEN A; BLUNDELL JE; ASTRUP A: "Reproducibility, power and validity of visual analogue scares in assessment of appetite sensations in single test meal studies", INTERNATIONAL JOURNAL OF OBESITY, vol. 24, 2000, pages 38 - 48
FRASSETTO ET AL., EUR. J. CLINICAL NUT., vol. 63, 2009, pages 947 - 955
FRASSETTO L A ET AL: "Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet", EUROPEAN JOURNAL OF CLINICAL NUTRITION, NATURE PUBLISHING GROUP, GB, vol. 63, no. 8, 1 August 2009 (2009-08-01), pages 947 - 955, XP008131253, ISSN: 0954-3007, [retrieved on 20090211], DOI: 10.1038/EJCN.2009.4 *
GINE BORDONABA, J ET AL., J. AGRIC. FOOD CHEM., vol. 56, 2008, pages 7422 - 7430
GORBOULEV ET AL., DIABETES, vol. 61, 2012, pages 187 - 196
JÃNSSON TOMMY ET AL: "A paleolithic diet is more satiating per calorie than a mediterranean-like diet in individuals with ischemic heart disease", NUTRITION & METABOLISM, BIOMED CENTRAL. LONDON, GB, vol. 7, no. 1, 30 November 2010 (2010-11-30), pages 85, XP021089866, ISSN: 1743-7075, DOI: 10.1186/1743-7075-7-85 *
JEW ET AL., J. MEDICINAL FOOD, vol. 12, no. 5, 2009, pages 925 - 934
JEW S ET AL: "Evolution of the human diet: linking our ancestral diet to modernfunctional foods as a means of chronic diseases prevention", JOURNAL OF MEDICINAL FOOD, MARY ANN LIEBERT, LARCHMONT, NY, US, vol. 12, no. 5, 1 January 2009 (2009-01-01), pages 925 - 934, XP002616612, ISSN: 1096-620X, [retrieved on 20091026], DOI: 10.1089/JMF.2008.0268 *
JONSSON ET AL., CARDIOVASCULAR DIABETOLOGY, vol. 8, 2009, pages 35
JONSSON ET AL., NUTRITION AND METABOLISM, vol. 7, 2010, pages 85
JÖNSSON T ET AL: "Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study", CARDIOVASCULAR DIABETOLOGY, BIOMED CENTRAL, LONDON, GB, vol. 8, no. 35, 16 July 2009 (2009-07-16), pages 1 - 14, XP002616615, ISSN: 1475-2840, DOI: 10.1186/1475-2840-8-35 *
KORNER J ET AL., SURG OBES RELAT DIS, vol. 3, 2007, pages 597 - 560
LE ROUX ET AL., ANN SURG, vol. 243, 2006, pages 108 - 14
LINDEBERG ET AL., DIABETOLOGICA, vol. 50, 2007, pages 1795 - 1807
LINDEBERG S ET AL: "A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease", DIABETOLOGIA, SPRINGER, BERLIN, DE, vol. 50, no. 9, 1 September 2007 (2007-09-01), pages 1795 - 1807, XP002616613, ISSN: 0012-186X, [retrieved on 20070622], DOI: 10.1007/S00125-007-0716-Y *
MEYER, M.D. ET AL., J. AGRIC. FOOD CHEM., vol. 56, 2008, pages 7439 - 7445
MIYAWAKI, K ET AL., NATURE MEDICINE, vol. 8, 2002, pages 738 - 742
NAUCK ET AL., DIABETOLOGIA, vol. 54, 2011, pages 10 - 18
NEFF ET AL., DIABETES, METABOLIC SYNDROME AND OBESITY: TARGETS AND THERAPY, vol. 3, 2010, pages 263 - 273
PEDERSEN-BJERGAARD ET AL., SCAND J CLIN LAB INVEST, vol. 56, 1996, pages 497 - 503
RENUKA, NEUROCHEM RES, vol. 31, no. 3, 2006, pages 313 - 20
STRATTON RJ; STUBBS RJ; HUGHES D; KING N; BLUNDELL JE; ELIA M: "Comparison of the traditional paper visual analogue scale questionnaire with an Apple Newton electronic appetite rating system (EARS) in free living subjects feeding ad libitum", EUROPEAN JOURNAL OF CLINICAL NUTRITION, vol. 52, 1998, pages 737 - 41
STUBBS RJ; HUGHES DA; JOHNSTONE AM ET AL.: "The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings", BRITISH JOURNAL OF NUTRITION, vol. 84, 2000, pages 405 - 15
SUZUKI, PEPTIDES, vol. 25, no. 10, 2004, pages 1803 - 8
TORRONEN ET AL., BRITISH J. NUTRITION, vol. 1-7, 2011
TUMBAS ET AL., ACTA PERIODICA TECHNOLOGICA, vol. 35, 2004, pages 265 - 273
VELIOGLU ET AL., J. OF AGRICULTURAL AND FOOD CHEM., vol. 46, 1998, pages 4113 - 4117

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015182955A (ja) * 2014-03-20 2015-10-22 学校法人中部大学 Ｇｌｐ−１分泌促進剤
WO2021252467A1 (en) * 2020-06-09 2021-12-16 H.J. Heinz Company Brands Llc Modular meal system
USD1057556S1 (en) 2021-10-29 2025-01-14 H. J. Heinz Company Brands Llc Tray
USD1085868S1 (en) 2021-10-29 2025-07-29 H. J. Heinz Company Brands Llc Tray

Also Published As

Publication number Publication date
EA201491050A1 (ru) 2014-09-30
AU2012343964A1 (en) 2014-04-24
IN2014MN00932A (https=) 2015-04-17
US9386792B2 (en) 2016-07-12
AU2012343964B2 (en) 2015-02-05
US20160286841A1 (en) 2016-10-06
US20140308392A1 (en) 2014-10-16
CA2852032A1 (en) 2013-06-06
EA027364B1 (ru) 2017-07-31
ZA201402770B (en) 2015-11-25
CN104039170A (zh) 2014-09-10
BR112014010107A2 (pt) 2017-04-25
EP2785201A1 (en) 2014-10-08
US9750272B2 (en) 2017-09-05

Similar Documents

Publication Publication Date Title
Wang et al. Regular intake of white kidney beans extract (Phaseolus vulgaris L.) induces weight loss compared to placebo in obese human subjects
Jane et al. Effects of daily consumption of psyllium, oat bran and polyGlycopleX on obesity-related disease risk factors: A critical review
McCrory et al. Pulse consumption, satiety, and weight management
Greger A whole food plant-based diet is effective for weight loss: the evidence
Törrönen et al. Postprandial glucose, insulin, and free fatty acid responses to sucrose consumed with blackcurrants and lingonberries in healthy women
US9750272B2 (en) Meal intended for human consumption
Lam et al. The influence of whey protein and glycomacropeptide on satiety in adult humans
Djurica et al. Effects of a dietary strawberry powder on parameters of vascular health in adolescent males
Józefczuk et al. Mulberry leaf extract decreases digestion and absorption of starch in healthy subjects—A randomized, placebo-controlled, crossover study
Quek et al. Impact of protein-rich meals on glycaemic response of rice
US20170173099A1 (en) Compositions and Methods for Increasing the Suppression of Hunger and Reducing the Digestibility of Non-Fat Energy Satiety
US10149882B2 (en) Weight management systems and related methods
Campos‐Vega et al. Spent coffee (Coffea arabica L.) grounds promote satiety and attenuate energy intake: A pilot study
Jung et al. Uncooked rice of relatively low gelatinization degree resulted in lower metabolic glucose and insulin responses compared with cooked rice in female college students
O'Connor et al. A novel fiber composite ingredient incorporated into a beverage and bar blunts postprandial serum glucose and insulin responses: A randomized controlled trial
Zin et al. Effect of biscuits and muffins added with cornlettes powder on the glycemic responses of healthy individuals
Shoji et al. Effects of dietary blueberry (Vaccinium ashei Reade) leaves on mildly postprandial hypertriglyceridemia
Gu Effects of grain sorghum muffin on blood glucose and insulin responses in prediabetic men
CN102204671A (zh) 一种含有桑属浆果的组合物
Giuntini et al. Consumption of ‘Moro’and ‘Pera’orange juices does not increase glycaemic and insulinaemic responses to other foods in adults
Rayo Role of Almonds in Physical Performance
Walker Public health and the prevention of type 2 diabetes
Pottgen Rice Consumption and effects of rice cake, Seolgitteok, on human health
Moyad Fad diets and obesity–Part II: An introduction to the theory behind low-carbohydrate diets
Pellazgu Insulin Resistance Syndrome-the Sensitive IRS

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12791209

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2852032

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2012343964

Country of ref document: AU

Date of ref document: 20121128

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 14359487

Country of ref document: US

NENP Non-entry into the national phase
WWE Wipo information: entry into national phase

Ref document number: 201491050

Country of ref document: EA

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112014010107

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112014010107

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20140428